Core Laboratories Joint Venture Agreement
VIBGYOR Scientific Research, genae associates, Cardiovascular Center Aalst and J.B. Dahm, MD have reached an agreement to form a Core Laboratories joint venture, called imaeon.
Core Laboratories joint venture agreement between genae associates, VIBGYOR Scientific Research, Cardiovascular Center Aalst and J.B. Dahm
6 October 2008 - Antwerp, Ahmedabad, Aalst, Göttingen
VIBGYOR Scientific Research, genae associates, Cardiovascular Center Aalst and J.B. Dahm, MD have reached an agreement to form a Core Laboratories joint venture, called imaeon.
imaeon initially will focus on the performance of medical images analysis for clinical research projects, including but not limited to: quantitative coronary and peripheral angiography (QCA, QVA), computed tomography (CT) angiography, intravascular ultrasound (IVUS) and IVUS related
techniques, multiple gated acquisition scan (MUGA), optical coherence tomography (OCT), magnetic resonance imaging (MRI), multi slice computer tomography (MSCT), electrocardiogram (ECG) and ECHO assessments.
While meeting or exceeding all quality standards in a timely and cost-effective manner, imaeon will offer expert evaluations of medical images from multi-modality environments and unsurpassed quality clinical research services. It will operate from the main facilities and offices in Ahmedabad,
India and from the subsidiary in Antwerp, Belgium and focus on the pharmaceutical, biomedical and medical device industries.
About Cardiovasculair Onderzoek Aalst CVBA
Cardiovasculair Onderzoek Aalst, with principal offices in Aalst, Belgium, provides consultancy assignments and logistics support related to scientific research and scientific studies for physicians, hospitals, universities, pharmaceutical institutions, governments and governmental institutions.
Contact
Paul Nellens, MD - paul.nellens@olvz-aalst.be
About genae associates nv
genae is a privately held NV/SA with principal offices in Antwerp, Belgium and is ISO 9001:2000 certified for CRO, Core Laboratories and Services Provider for the Medical Industries. These global services include but are not limited to Clinical Data Management, Electronic Data Capture
(EDC), Statistical Analysis, Scientific & Medical Writing, CE-Marking (MDD) and Training & Education.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
